175 related articles for article (PubMed ID: 32453715)
1. Myocardial protection by nanomaterials formulated with CHIR99021 and FGF1.
Fan C; Oduk Y; Zhao M; Lou X; Tang Y; Pretorius D; Valarmathi MT; Walcott GP; Yang J; Menasche P; Krishnamurthy P; Zhu W; Zhang J
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32453715
[TBL] [Abstract][Full Text] [Related]
2. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
Fan C; Tang Y; Zhao M; Lou X; Pretorius D; Menasche P; Zhu W; Zhang J
J Mol Cell Cardiol; 2020 Apr; 141():1-10. PubMed ID: 32169551
[TBL] [Abstract][Full Text] [Related]
3. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
4. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration.
Formiga FR; Pelacho B; Garbayo E; Imbuluzqueta I; Díaz-Herráez P; Abizanda G; Gavira JJ; Simón-Yarza T; Albiasu E; Tamayo E; Prósper F; Blanco-Prieto MJ
J Control Release; 2014 Jan; 173():132-9. PubMed ID: 24200746
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.
Qi Q; Lu L; Li H; Yuan Z; Chen G; Lin M; Ruan Z; Ye X; Xiao Z; Zhao Q
Int J Nanomedicine; 2017; 12():4835-4848. PubMed ID: 28744119
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis.
Hou L; Guo J; Xu F; Weng X; Yue W; Ge J
Basic Res Cardiol; 2018 Jun; 113(4):28. PubMed ID: 29892894
[TBL] [Abstract][Full Text] [Related]
7. TT-10-loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction.
Chen W; Pretorius D; Zhou Y; Nakada Y; Yang J; Zhang J
JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34676829
[TBL] [Abstract][Full Text] [Related]
8. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.
Engel FB; Hsieh PC; Lee RT; Keating MT
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15546-51. PubMed ID: 17032753
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
[TBL] [Abstract][Full Text] [Related]
12. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
[TBL] [Abstract][Full Text] [Related]
13. VEGF nanoparticles repair the heart after myocardial infarction.
Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176
[TBL] [Abstract][Full Text] [Related]
14. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling.
Mewhort HE; Turnbull JD; Meijndert HC; Ngu JM; Fedak PW
J Thorac Cardiovasc Surg; 2014 May; 147(5):1650-9. PubMed ID: 24075463
[TBL] [Abstract][Full Text] [Related]
15. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction.
Yang D; Fu W; Li L; Xia X; Liao Q; Yue R; Chen H; Chen X; An S; Zeng C; Wang WE
Clin Sci (Lond); 2017 Dec; 131(24):2919-2932. PubMed ID: 29162747
[TBL] [Abstract][Full Text] [Related]
17. NGF nanoparticles enhance the potency of transplanted human umbilical cord mesenchymal stem cells for myocardial repair.
Luo W; Gong Y; Qiu F; Yuan Y; Jia W; Liu Z; Gao L
Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1959-H1974. PubMed ID: 33769916
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
19. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
Okada H; Takemura G; Kosai K; Tsujimoto A; Esaki M; Takahashi T; Nagano S; Kanamori H; Miyata S; Li Y; Ohno T; Maruyama R; Ogino A; Li L; Nakagawa M; Nagashima K; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H616-26. PubMed ID: 19151252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
